165 related articles for article (PubMed ID: 1508218)
41. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
42. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.
Fuh G; Wells JA
J Biol Chem; 1995 Jun; 270(22):13133-7. PubMed ID: 7768908
[TBL] [Abstract][Full Text] [Related]
43. Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion.
Porter TE; Grandy D; Bunzow J; Wiles CD; Civelli O; Frawley LS
Endocrinology; 1994 Mar; 134(3):1263-8. PubMed ID: 8119166
[TBL] [Abstract][Full Text] [Related]
44. Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript.
Gellersen B; DiMattia GE; Friesen HG; Bohnet HG
Mol Cell Endocrinol; 1989 Jun; 64(1):127-30. PubMed ID: 2759338
[TBL] [Abstract][Full Text] [Related]
45. Production and characterization of biologically active Ala-Ser-(His)6-Ile-Glu-Gly-Arg-human prolactin (tag-hPRL) secreted in the periplasmic space of Escherichia coli.
Morganti L; Huyer M; Gout PW; Bartolini P
Biotechnol Appl Biochem; 1996 Feb; 23(1):67-75. PubMed ID: 8867898
[TBL] [Abstract][Full Text] [Related]
46. Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors.
Nowak RA; Rein MS; Heffner LJ; Friedman AJ; Tashjian AH
J Clin Endocrinol Metab; 1993 May; 76(5):1308-13. PubMed ID: 8496322
[TBL] [Abstract][Full Text] [Related]
47. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
Shiu RP; Paterson JA
Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
[TBL] [Abstract][Full Text] [Related]
48. Expression and localization of prolactin messenger ribonucleic acid in the human immune system.
Wu H; Devi R; Malarkey WB
Endocrinology; 1996 Jan; 137(1):349-53. PubMed ID: 8536634
[TBL] [Abstract][Full Text] [Related]
49. [Action mechanism of pituitary hormones--receptor and signal transduction--prolactin].
Aono T; Yokoyama Y
Nihon Rinsho; 1993 Oct; 51(10):2631-5. PubMed ID: 8254931
[TBL] [Abstract][Full Text] [Related]
50. Use of prolactin receptor antagonist to better understand prolactin regulation of pituitary homeostasis.
Ferraris J; Bernichtein S; Pisera D; Goffin V
Neuroendocrinology; 2013; 98(3):171-9. PubMed ID: 23969780
[TBL] [Abstract][Full Text] [Related]
51. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
Manfroid I; Van de Weerdt C; Baudhuin A; Martial JA; Muller M
Mol Cell Endocrinol; 2005 Jan; 229(1-2):127-39. PubMed ID: 15607537
[TBL] [Abstract][Full Text] [Related]
52. Characterization of lactogen receptor-binding site 1 of human prolactin.
Kinet S; Goffin V; Mainfroid V; Martial JA
J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911
[TBL] [Abstract][Full Text] [Related]
53. Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R.
Beck MT; Peirce SK; Chen WY
Oncogene; 2002 Aug; 21(33):5047-55. PubMed ID: 12140755
[TBL] [Abstract][Full Text] [Related]
54. Prolactin is a local growth factor in rat mammary tumors.
Mershon J; Sall W; Mitchner N; Ben-Jonathan N
Endocrinology; 1995 Aug; 136(8):3619-23. PubMed ID: 7628401
[TBL] [Abstract][Full Text] [Related]
55. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse.
Gala RR; Shevach EM
Endocrinology; 1993 Oct; 133(4):1617-23. PubMed ID: 8404602
[TBL] [Abstract][Full Text] [Related]
56. Novel reagents for human prolactin research: large-scale preparation and characterization of prolactin receptor extracellular domain, non-pegylated and pegylated prolactin and prolactin receptor antagonist.
Oclon E; Solomon G; Hayouka Z; Salame TM; Goffin V; Gertler A
Protein Eng Des Sel; 2018 Jan; 31(1):7-16. PubMed ID: 29281090
[TBL] [Abstract][Full Text] [Related]
57. Prolactin control of growth and prolactin autoregulation in cultured human pituitary cells.
Hosojima H; Wyche JH
Horm Res; 1985; 21(4):240-5. PubMed ID: 4007784
[TBL] [Abstract][Full Text] [Related]
58. Bovine corpus luteum is an extrapituitary site of prolactin production.
Shibaya M; Murakami S; Tatsukawa Y; Skarzynski DJ; Acosta TJ; Okuda K
Mol Reprod Dev; 2006 Apr; 73(4):512-9. PubMed ID: 16435374
[TBL] [Abstract][Full Text] [Related]
59. Prolactin and its receptor in human endometrium.
Tseng L; Mazella J
Semin Reprod Endocrinol; 1999; 17(1):23-7. PubMed ID: 10406072
[TBL] [Abstract][Full Text] [Related]
60. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
